<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="EN" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">J Neurosci Methods</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>Journal of neuroscience methods</journal-title></journal-title-group><issn pub-type="ppub">0165-0270</issn><issn pub-type="epub">1872-678X</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC2669956</article-id><article-id pub-id-type="pmcid-ver">PMC2669956.1</article-id><article-id pub-id-type="pmcaid">2669956</article-id><article-id pub-id-type="pmcaiid">2669956</article-id><article-id pub-id-type="manuscript-id">NIHMS4974</article-id><article-id pub-id-type="pmid">15848236</article-id><article-id pub-id-type="doi">10.1016/j.jneumeth.2004.10.016</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS4974</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA4974</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Development of a simultaneous PET/microdialysis method to identify the optimal dose of <sup>11</sup>C-raclopride for small animal imaging</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Schiffer</surname><given-names initials="WK">Wynne K.</given-names></name><xref ref-type="aff" rid="A1">a</xref><xref ref-type="aff" rid="A2">b</xref><xref ref-type="author-notes" rid="FN1">*</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Alexoff</surname><given-names initials="DL">David L.</given-names></name><xref ref-type="aff" rid="A2">b</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Shea</surname><given-names initials="C">Colleen</given-names></name><xref ref-type="aff" rid="A2">b</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Logan</surname><given-names initials="J">Jean</given-names></name><xref ref-type="aff" rid="A2">b</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Dewey</surname><given-names initials="SL">Stephen L.</given-names></name><xref ref-type="aff" rid="A1">a</xref><xref ref-type="aff" rid="A2">b</xref></contrib><aff id="A1"><label>a</label> Department of Neurobiology and Behavior, State University of New York at Stony Brook, Stony Brook, NY 11794-5230, USA</aff><aff id="A2"><label>b</label> Chemistry Department, Building 555, Brookhaven National Laboratory, Upton, NY 11973-5000, USA</aff></contrib-group><author-notes><fn fn-type="corresp" id="FN1"><label>*</label><p id="P1">Corresponding author. Tel.: +1 631 344 4395; fax: +1 586 279 6268. <italic>E-mail address:</italic> <email>wynne@bnl.gov</email> (W.K. Schiffer).</p></fn></author-notes><pub-date pub-type="epub"><day>8</day><month>12</month><year>2004</year></pub-date><pub-date pub-type="ppub"><day>15</day><month>5</month><year>2005</year></pub-date><volume>144</volume><issue>1</issue><issue-id pub-id-type="pmc-issue-id">178228</issue-id><fpage>25</fpage><lpage>34</lpage><pub-history><event event-type="nihms-submitted"><date><day>01</day><month>12</month><year>2005</year></date></event><event event-type="pmc-release"><date><day>17</day><month>04</month><year>2009</year></date></event><event event-type="pmc-live"><date><day>17</day><month>04</month><year>2009</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2021-01-02 19:16:26.713"><day>02</day><month>01</month><year>2021</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-4974.pdf"/><abstract><p id="P2">In the field of small animal positron emission tomography (PET), the assumptions underlying human and primate kinetic models may not be sustained in rodents. That is, the threshold dose at which a pharmacologic response occurs may be lower in small animals. In order to define this relationship, we combined microPET imaging using <sup>11</sup>C-raclopride with microdialysis measures of extracellular fluid (ECF) dopamine (DA). In addition, we performed a series of studies in which a known mass of raclopride was microinfused into one striatum prior to a high specific activity (SA) systemic injection of <sup>11</sup>C-raclopride. This single-injection approach provided a high and low SA region of radiotracer binding in the same animal during the same scanning session. Our data demonstrate that the binding potential (BP) declines above 3.5 pmol/ml (0.35 &#956;g), with an ED<sub>50</sub> of 8.55 &#177; 5.62 pmol/ml. These data also provide evidence that BP may be compromised by masses of raclopride below 2.0 pmol/ml (0.326 &#956;g). Increases in ECF DA were produced by mass doses of raclopride over 3.9 pmol/ml (0.329 &#956;g) with an ED<sub>50</sub> of 8.53 &#177; 2.48 pmol/ml. Taken together, it appears that an optimal range of raclopride mass exists between 2.0 and 3.5 pmol/ml, around which the measured BP can be compromised by system sensitivity, endogenous DA, or excessive competition with unlabeled compound.</p></abstract><kwd-group><kwd>MicroPET</kwd><kwd>Rodent</kwd><kwd><sup>11</sup>C-raclopride</kwd><kwd>D<sub>2</sub> receptors</kwd><kwd>Microdialysis</kwd><kwd>Mass effect</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>